RODRIGO
BARDERAS MANCHADO
Investigador hasta 2017
Hospital Universitario Puerta de Hierro
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (8)
2022
-
Seroreactivity Against Tyrosine Phosphatase PTPRN Links Type 2 Diabetes and Colorectal Cancer and Identifies a Potential Diagnostic and Therapeutic Target
Diabetes, Vol. 71, Núm. 3, pp. 497-510
2016
-
Toward liquid biopsy: Determination of the humoral immune response in cancer patients using halotag fusion protein-modified electrochemical bioplatforms
Analytical Chemistry, Vol. 88, Núm. 24, pp. 12339-12345
2015
-
A proteomic analysis reveals that snail regulates the expression of the nuclear orphan receptor nuclear receptor subfamily 2 group F member 6 (Nr2f6) and interleukin 17 (IL-17) to inhibit adipocyte differentiation
Molecular and Cellular Proteomics, Vol. 14, Núm. 2, pp. 303-315
2013
-
FGFR4 Role in Epithelial-Mesenchymal Transition and Its Therapeutic Value in Colorectal Cancer
PLoS ONE, Vol. 8, Núm. 5
-
In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration, and invasion
Molecular and Cellular Proteomics, Vol. 12, Núm. 6, pp. 1602-1620
-
Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer
Clinical Cancer Research, Vol. 19, Núm. 21, pp. 6006-6019
2012
-
An optimized predictor panel for colorectal cancer diagnosis based on the combination of tumor-associated antigens obtained from protein and phage microarrays
Journal of Proteomics, Vol. 75, Núm. 15, pp. 4647-4655
2009
-
SNAI1 expression in colon cancer related with CDH1 and VDR downregulation in normal adjacent tissue
Oncogene, Vol. 28, Núm. 49, pp. 4375-4385